# Hormone Responsive Cancers (HRC)

> **NIH NIH P30** · UNIVERSITY OF MARYLAND BALTIMORE · 2020 · $38,032

## Abstract

16.0 Abstract: Hormone Responsive Cancers Program 
The overarching goal of the Hormone Responsive Cancers (HRC) Program of UMGCC is to reduce morbidity 
and mortality from cancers of hormone-responsive tissues. To achieve this mission, the program focuses on 
three specific themes and related aims: Theme 1: Therapeutic strategies against hormone-responsive 
tumors—identify new agents to target malignancies that remain responsive to hormone manipulation; Theme 
2: Mechanisms of innate and acquired hormone resistance—identify and target the mechanisms that 
confer de novo or acquired resistance to hormone manipulation; and Theme 3: Invasion and metastasis— 
identify the mechanisms that promote tumor dissemination and identify therapeutic strategies to target these 
mechanisms. 
The HRC Program has 47 members representing 16 academic departments and 5 schools/colleges of the 
University of Maryland. Members of the program conduct cancer-focused research that receives $7.1 million 
total annual funding, including $3.4 million from NCI and $2.6 million from other peer-reviewed sources. In 
addition, HRC Program members receive over $1 million annually from non-peer-reviewed funding sources. 
Between January 2010 and December 2014, HRC members authored 407 cancer-related publications, of 
which 30 percent resulted from intraprogrammatic and 23 percent from interprogrammatic collaborations. 
Twenty-two percent of the publications represent collaborations with external investigators. Research efforts of 
HRC faculty are supported by extensive use of the BSS, FCSS, GSS, ISS, PBSS, and TLSS.

## Key facts

- **NIH application ID:** 9985000
- **Project number:** 5P30CA134274-13
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** STUART S MARTIN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $38,032
- **Award type:** 5
- **Project period:** 2008-08-08 → 2021-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9985000

## Citation

> US National Institutes of Health, RePORTER application 9985000, Hormone Responsive Cancers (HRC) (5P30CA134274-13). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/9985000. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*